1
Ouaddouh, C., Duijster, J. W., Lieber, T., van Hunsel, F. P.A.M.
Veröffentlicht in: Ouaddouh , C , Duijster , J W , Lieber , T & van Hunsel , F P A M 2024 , ' The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands ' , Expert Opinion on Drug Safety , vol. 23 , no. 3 . https://doi.org/10.1080/14740338.2023.2267971;
2024
Veröffentlicht in: Ouaddouh , C , Duijster , J W , Lieber , T & van Hunsel , F P A M 2024 , ' The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands ' , Expert Opinion on Drug Safety , vol. 23 , no. 3 . https://doi.org/10.1080/14740338.2023.2267971;
2024